We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Prioritizing Drugs Targeting IFNAR2 and ACE2 To Treat COVID-19

News   Apr 12, 2021 | Original story from Veterans Affairs Research Communications

 
Prioritizing Drugs Targeting IFNAR2 and ACE2 To Treat COVID-19

Credit: Pete Linforth/ Pixabay

 
 
Advertisement
 

RELATED ARTICLES

2021 Gruber Neuroscience Prize Awarded to Hearing Loss and Autism Pioneers

News

The 2021 Gruber Neuroscience Prize has been awarded to neuroscientists Christine Petit of the Institut Pasteur and Christopher A. Walsh of Harvard Medical School, for their groundbreaking work in revealing the genetic and molecular mechanisms behind the development of inherited neurodevelopmental disorders.

READ MORE

Gene Switches Could Turn Early Birds Into Night Owls

News

Researchers have identified a set of genes, called clock genes, that control circadian rhythms, the natural process that governs sleep and waking patterns in humans, animals, and plants.

READ MORE

Enhanced Immune Control Found in Rare Few Who Can Naturally Manage HIV

News

Scientists have shown that elite controllers, a rare subset of people whose immune system can control HIV without the use of drugs, have myeloid dendritic cells, part of the innate immune response, that display traits of a trained innate immune cell.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE